MedTrace Logo

Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care

NCT04013737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2021-08-31

Study results available
· View outcomes & findings →

Summary

Antimicrobials (drugs that kill or stop the growth of microorganisms including bacteria, thereby treating infections) commonly used to treat patients with infections are becoming less effective over time as bacteria develop resistance to them. Antimicrobial usage itself can lead to development and spread of antimicrobial resistance. Antimicrobial resistance is now a major threat to patient safety. To conserve the effectiveness of antimicrobials the investigator need to develop ways to use them more sensibly healthcare professionals who diagnose and treat infections must be able to access antimicrobial guidelines and test results at the patient bedside. This needs to be provided rapidly and with support to make sure that the decisions on prescribing antimicrobials are the best that can be made.

Conditions

Interventions

DEVICE

EPIC IMPOC

Clinical Decision Support System for antibiotic prescribing.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alison Holmes · Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2019-08-08
Completion
2019-08-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013737 on ClinicalTrials.gov